Marcap | search
Click here to view Marcap news from 60+ newspapers.
Bookmark or Share- About - MARCAPToday, MARCAP has data from every single phase III radiotherapy randomized trial in localized prostate cancer assessing the use or duration of ADT that collected data on metastatic and survival outcomes. Data collection is ongoing for future projects across the prostate cancer disease spectrum.
- MARCAP“MARCAP allows the generation of the highest level of evidence for the optimal treatment for patients with prostate cancer.” Created in 2020, MARCAP is the culmination of years of work from co-Principal Investigators, Dr. Dan Spratt and Dr. Amar Kishan.
- Our Findings — MARCAPThis represents the first individual patient meta-analysis of every single phase III trial that has been published assessing the benefit of short-term ADT to radiotherapy that reported metastasis and survival outcomes.
- Team Members - MARCAPThank you to our scientific collaborators that have made this possible J.G. Armstrong, M. Bolla, P.C. Boutros, J. Brown, N. Carrier, C. Cruickshank, D.P. Dearnaley, J ...
More
